Clinical Trials Browser

Phase 3 × Atomoxetine Hydrochloride × Clear all

NCT00255138 2022-04-01

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

Phase 3 Withdrawn

Neoplasms